Skip to main content

Kwick Forensic Solutions Ltd IPO

Status: Closed

Overview

IPO date
27 Aug 2026 to 31 Aug 2026
Face value
₹ 0 per share
Price
₹ 85 to ₹90 per share
Issue Size
5,641,600 shares
(aggregating up to ₹ 50.77 Cr)
Allotment Date
01 Sept 2026
Listing at
NSE
Issue type
Book Building - SME
Sector
Healthcare

This image for unlock stock of the monthUnlock Stock of the Month

T&C*

Strengths vs Risks of Kwick Forensic Solutions Ltd

Know the pros & cons

Strengths

  • Experienced Promoter and management team with strong industry expertise and successful track record.
  • Diversified revenue streams.
  • Deep relationships with government/law-enforcement clients.
  • Long-standing OEM relationships.
  • Pan-India presence.
  • Highly passionate & focused on Quality Assurance, backed by ISO certifications.
  • Efficient operational team.

Risks

  • The company's products and services are significantly concentrated in the certain states, particularly Bihar and Gujarat. Any adverse developments in these regions may materially impact its business, financial condition, results of operations, and cash flows.
  • The company does not have long-term agreements with a majority of its customers. Any changes or cancellations to its orders or the company's inability to forecast demand for its products may adversely affect the company's business, results of operations and financial condition.
  • The company derives majority of its revenue from Sales of Goods and Sales of Services and any reduction in the demand of such segment could have an adverse effect on the company's business, results of operations and financial conditions.
  • The average cost of acquisition of Equity Shares by the company's Promoters Selling Shareholders could be lower than the Offer price determined in consultation with Book Running Lead Manager in accordance with the SEBI ICDR Regulations.
  • Any delays in filing Advance Tax, EPF, GST returns, TDS Return may lead to regulatory penalties and may have an adverse impact on the company's financial and operational performance.
  • The company is dependent on a limited number of suppliers for procurement of its raw materials, and the loss of any one or more of the company's major suppliers would have a material adverse effect on its business operations and profitability.
  • There have been instances in the past where the company's forensic product activities were not being aligned with the main object clause of its Memorandum of Association.
  • The company sources its products from the international market i.e., China, USA, Turkey, Japan, Italy etc. Any adverse developments affecting its procurement in this region could materially and adversely impact the company's revenue and results of operations.
  • The Company has negative cash flows in the past years, details of which are given below. Sustained negative cash flow could impact its growth and business.
  • The company drives 55.22%, 78.91% and 86.98%, in FY 2026, 2025 and 2024 revenue from business transactions with government entities or agencies. Any change in the governments in the markets in which the company operates, change in policies and/or its inability to recover payments therefrom in a timely manner or at all, would adversely affect the company's operations and revenues which in turn would adversely affect its profitability.
  • The company's business is working capital intensive. If the company experiences insufficient cash flows to meet required payments on its working capital requirements, there may be an adverse effect on the results of the company's operations.
  • The company's Registered office and Branch Office (i.e., For R&D division, Demonstration centre and private forensic laboratory set up as a proof of concept) is on rental premises and there can be no assurance that these rental agreements will be renewed upon termination or that the company will be able to obtain other premise on rental on same or similar commercial terms.
  • The company's Purchases of Goods constitute a significant portion of its total expenditure and revenue from operations. Any adverse change in the supply availability or pricing of goods procured by it may negatively impact the company's business, results of operations, cash flows and financial condition.
  • The company's contingent liabilities as stated in the company's Restated Financial Statements, could adversely affect its financial condition.
  • The company's BRLM is Subject to SEBI Regulations and general routine Inspections conducted under it.
  • Certain pre-IPO investors have acquired Equity Shares at an effective cost lower than the Offer Price and may dispose of such Equity Shares after expiry of lock-in periods, which could adversely affect the market price of the company's Equity Shares.
  • The company has certain outstanding litigation against the Company, an adverse outcome of which may adversely affect its business, reputation and results of operations.
  • Delays/non-compliances in employee-related statutory filings i.e., EPF and ESIC may attract interest, damages, penalties and adverse orders; any such amounts will be paid from internal accruals.
  • The company's trademarks related to the company logo and products are pending registration and the company does not currently enjoy statutory protection under Indian trademark law. Any inability to obtain and protect its intellectual property rights may adversely affect the company's business, financial condition, reputation, and results of operations.
  • There are certain discrepancies and non-compliances noticed in some of the company's corporate records relating to forms filed with the Registrar of Companies. Further, there have been instances in the past wherein the Company failed to comply with the provisions of the Companies Act, 2013.
  • The company relies on OEM Partners for its Products and Services and any disruption in these relationships could adversely affect the company's operations, revenue, and overall business performance.
  • No educational qualifications have been disclosed for one of the company's directors, which could affect stakeholders perception of its management.
  • The company's directors, promoters, Independent Director and Member of Senior Management is unable to provide an authentic copy of experience certificates , which could potentially affect the company's disclosures, reputation, and stakeholders' perception.
  • If the company fails to retain its employees, including Key Managerial Personnel ("KMP") and Senior Management Personnel ("SMP"), or if the company experiences higher levels of attrition in the future, its business operations, results of operations and financial condition may be adversely affected.
  • The company's business is operating under various laws which requires it to obtain approvals from the concerned statutory/regulatory authorities in the ordinary course of business and the company's inability to obtain, maintain or renew requisite statutory and regulatory permits and approvals for its business operations could materially and adversely affect the company's business, prospects, results of operations and financial condition.
  • Failures to offer customer support in a timely and effective manner may adversely affect the company's relationship with its customers.
  • The success of the Company depends on continuous product development and enhancement, and any adverse developments in the company's products or services may materially and adversely affect its business, financial condition, results of operations, and cash flows.
  • Changing regulations in India could lead to new compliance requirements that are uncertain. The regulatory environment in which the company operates is evolving and is subject to change.
  • The company relies on third-party transporters for sourcing raw materials from its suppliers and delivering products to the company's customers. The absence of formal agreements with these providers exposes it to risks of delays, disruptions, and non-performance, which may adversely impact the company's business, financial condition, and results of operations.
  • Delays in execution of the company's orders may lead to cost escalation and adversely affect its financial performance.
  • The company will not receive any proceeds from the Offer for Sale portion.
  • The company has in the past entered into related party transactions and may continue to do so in the future, may potentially involve conflicts of interest and impose certain liabilities on the Company.
  • The company's success depends largely upon the services of its Directors, Promoter and other Key Managerial Personnel and the company's ability to attract and retain them.
  • The company's Promoter and WTD does not has any prior experience of being a director in any other listed company in India.
  • The company's Promoters and members of the Promoter Group will continue jointly to retain majority control over the Company after the Offer, which will allow them to determine the outcome of matters submitted to shareholders for approval.
  • The company's inability to procure and/or maintain adequate insurance cover in connection with its business may adversely affect the company's results of operations, cash flows and financial condition.
  • If the company is unable to update and enhance its existing products and services in a timely manner to keep pace with technological advancements and industry developments in the forensic sector, the company's customer satisfaction, competitiveness and operating results may be adversely affected.
  • Absence of comparable publicly listed companies may adversely affect investor perception, valuation, and marketability of the company's Securities.
  • The company's inability to manage inventory in an effective manner could affect its business.
  • Changing regulations in India could lead to new compliance requirements that are uncertain. The regulatory environment in which the company operates is evolving and is subject to change.
  • The Weighted average cost of acquisition of Equity Shares by the company's Promoters is lower than the issue price.
  • An inability to manage the company's growth could disrupt its business and reduce the company's profitability.
  • The company has issued Equity Shares during the preceding twelve months at a price which may be below the Issue Price.
  • The company's success depends largely upon the knowledge and experience of its Promoters and other Key Managerial Personnel. Any loss of the company's key managerial personnel or its ability to attract and retain them may adversely affect the company's business, operations and financial condition.
  • As the company continues to expand, managing its growth and the increasing complexity of the company's business may become challenging, potentially harming its brand and financial performance.
  • The company has relied on third-party industry sources i.e., D&B Report, and any inaccuracies in or reliance on such information may adversely affect investor perception.
  • The company's ability to pay dividends in the future may be affected by any material adverse effect on its future earnings, financial condition cash flows, working capital requirements, capital expenditures and restrictive covenants in the company's financing arrangements.
  • The Price of the company's Equity Shares may be volatile, or an active trading market may not develop.
  • The company cannot assure you that its equity shares will be listed on the SME platform of BSE in a timely manner or at all, which may restrict your ability to dispose of the equity shares.
  • Sale of Equity Shares by the company's Promoters or other significant shareholder(s) may adversely affect the trading price of the Equity Shares.
  • After this Issue, the price of the Equity Shares may be highly volatile, or an active trading market for the Equity Shares may not develop.
  • The Issue price of the company's Equity Shares may not be indicative of the market price of its Equity Shares after the Issue and the market price of the company's Equity Shares may decline below the issue price and you may not be able to sell your Equity Shares at or above the Issue Price.
Journey for how to check the allotment status

How to check the allotment status of Kwick Forensic Solutions Ltd IPO?

Follow the steps

IPO allotment status journey step 1
IPO allotment status journey step 2
IPO allotment status journey step 3
IPO allotment status journey step 4

Open link to the registrar using this URL (https://evault.kfintech.com/ipostatus/).

IPO reads

Stay updated with the latest IPO developments

More on IPOs

Navigate your way to other IPO resources

Latest videos on IPOs

IPO highlights & details!

FAQs on IPO

Get answers to all your questions here!

The IPO opens on 27 Aug 2026 & closes on 31 Aug 2026.

Kwick Forensic Solutions Limited was initially incorporated as 'Kwick Soft Solutions Private Limited' as a Private Company on March 4, 2005 with the Registrar of Companies, Tamil Nadu. Later, the name of the Company got changed from 'Kwick Soft Solutions Private Limited' to 'Kwick Integrated Forensic and Investigation Solutions Private Limited' on July 08, 2024 and again changed to 'Kwick Forensic Solutions Private Limited' on September 16, 2024. Now, the Company has got status converted to Public Limited Company via fresh Certificate of Incorporation issued by the Central Processing Centre on April 29, 2025. Company provides end-to-end forensic products and services across four segments-Forensic Science & Physical Evidence Solutions, Mobile CSI Vehicles, Cyber & Digital Forensics, and DNA Forensics-together with a services line for liquor detection scanner with manpower support. It serves police departments, forensic laboratories, fingerprint bureaus and training institutes nationwide involved in crime scene investigations and specialize in evidence identification, collection, digitization. etc. Currently, Company is operating through its registered office from Chennai. Initially, the Company focused on software development like 3D rendering, animation and simulation, serving the construction sector through 3D walkthroughs. In 2008, Company identified opportunities for forensic training by developing an Interactive Virtual Reality Crime Scene Simulator for training and proficiency testing of personnel responsible for crime scene management, for development of same, it has received the substantial support and, funding from the Ministry of Science & Technology, the Directorate of Forensic Science, and TIFAC (Technology Information, Forecasting and Assessment Council). From FY2015, Company expanded into fingerprint science. Gradually started and moved forward in forensic sciences, cyber/digital forensics, social-media and big-data analytics and has since specialised in handheld field devices that help investigators identify visible/invisible evidence and digitise it to support as proof of evidence. Company is planning the public offer of 56,40,000 equity shares of face value of Rs 10 per equity share, comprising a fresh issue of 45,60,000 equity shares and the offer for sale of 10,80,000 equity shares.

Kwick Forensic Solutions Ltd IPO will close on 31 Aug 2026.

  • Experienced Promoter and management team with strong industry expertise and successful track record.
  • Diversified revenue streams.
  • Deep relationships with government/law-enforcement clients.
  • Long-standing OEM relationships.
  • Pan-India presence.
  • Highly passionate & focused on Quality Assurance, backed by ISO certifications.
  • Efficient operational team.

S.No Promoters Name Pre Issue Shares Pre Issue Percentage Post Issue Shares Post Issue Percentage
1 Shammer Saralal Shah 9071904 53.76 8855904 41.31
2 Sejal Shammer Shah 3000000 17.78 2352000 10.97
3 Tulsidas Hinduja Ashok Kumar 1103632 6.54 887632 4.14
4 Saloni S Shah 475200 2.82 475200 2.22
5 Shefali S Shah 475200 2.82 475200 2.22
6 Bina Sanjay Shah 475200 2.82 475200 2.22
7 Sangita Malay Mehta 168744 1 168744 0.79
8 Sunita Amit Shah 168744 1 168744 0.79

  • The company's products and services are significantly concentrated in the certain states, particularly Bihar and Gujarat. Any adverse developments in these regions may materially impact its business, financial condition, results of operations, and cash flows.
  • The company does not have long-term agreements with a majority of its customers. Any changes or cancellations to its orders or the company's inability to forecast demand for its products may adversely affect the company's business, results of operations and financial condition.
  • The company derives majority of its revenue from Sales of Goods and Sales of Services and any reduction in the demand of such segment could have an adverse effect on the company's business, results of operations and financial conditions.
  • The average cost of acquisition of Equity Shares by the company's Promoters Selling Shareholders could be lower than the Offer price determined in consultation with Book Running Lead Manager in accordance with the SEBI ICDR Regulations.
  • Any delays in filing Advance Tax, EPF, GST returns, TDS Return may lead to regulatory penalties and may have an adverse impact on the company's financial and operational performance.
  • The company is dependent on a limited number of suppliers for procurement of its raw materials, and the loss of any one or more of the company's major suppliers would have a material adverse effect on its business operations and profitability.
  • There have been instances in the past where the company's forensic product activities were not being aligned with the main object clause of its Memorandum of Association.
  • The company sources its products from the international market i.e., China, USA, Turkey, Japan, Italy etc. Any adverse developments affecting its procurement in this region could materially and adversely impact the company's revenue and results of operations.
  • The Company has negative cash flows in the past years, details of which are given below. Sustained negative cash flow could impact its growth and business.
  • The company drives 55.22%, 78.91% and 86.98%, in FY 2026, 2025 and 2024 revenue from business transactions with government entities or agencies. Any change in the governments in the markets in which the company operates, change in policies and/or its inability to recover payments therefrom in a timely manner or at all, would adversely affect the company's operations and revenues which in turn would adversely affect its profitability.
  • The company's business is working capital intensive. If the company experiences insufficient cash flows to meet required payments on its working capital requirements, there may be an adverse effect on the results of the company's operations.
  • The company's Registered office and Branch Office (i.e., For R&D division, Demonstration centre and private forensic laboratory set up as a proof of concept) is on rental premises and there can be no assurance that these rental agreements will be renewed upon termination or that the company will be able to obtain other premise on rental on same or similar commercial terms.
  • The company's Purchases of Goods constitute a significant portion of its total expenditure and revenue from operations. Any adverse change in the supply availability or pricing of goods procured by it may negatively impact the company's business, results of operations, cash flows and financial condition.
  • The company's contingent liabilities as stated in the company's Restated Financial Statements, could adversely affect its financial condition.
  • The company's BRLM is Subject to SEBI Regulations and general routine Inspections conducted under it.
  • Certain pre-IPO investors have acquired Equity Shares at an effective cost lower than the Offer Price and may dispose of such Equity Shares after expiry of lock-in periods, which could adversely affect the market price of the company's Equity Shares.
  • The company has certain outstanding litigation against the Company, an adverse outcome of which may adversely affect its business, reputation and results of operations.
  • Delays/non-compliances in employee-related statutory filings i.e., EPF and ESIC may attract interest, damages, penalties and adverse orders; any such amounts will be paid from internal accruals.
  • The company's trademarks related to the company logo and products are pending registration and the company does not currently enjoy statutory protection under Indian trademark law. Any inability to obtain and protect its intellectual property rights may adversely affect the company's business, financial condition, reputation, and results of operations.
  • There are certain discrepancies and non-compliances noticed in some of the company's corporate records relating to forms filed with the Registrar of Companies. Further, there have been instances in the past wherein the Company failed to comply with the provisions of the Companies Act, 2013.
  • The company relies on OEM Partners for its Products and Services and any disruption in these relationships could adversely affect the company's operations, revenue, and overall business performance.
  • No educational qualifications have been disclosed for one of the company's directors, which could affect stakeholders perception of its management.
  • The company's directors, promoters, Independent Director and Member of Senior Management is unable to provide an authentic copy of experience certificates , which could potentially affect the company's disclosures, reputation, and stakeholders' perception.
  • If the company fails to retain its employees, including Key Managerial Personnel ("KMP") and Senior Management Personnel ("SMP"), or if the company experiences higher levels of attrition in the future, its business operations, results of operations and financial condition may be adversely affected.
  • The company's business is operating under various laws which requires it to obtain approvals from the concerned statutory/regulatory authorities in the ordinary course of business and the company's inability to obtain, maintain or renew requisite statutory and regulatory permits and approvals for its business operations could materially and adversely affect the company's business, prospects, results of operations and financial condition.
  • Failures to offer customer support in a timely and effective manner may adversely affect the company's relationship with its customers.
  • The success of the Company depends on continuous product development and enhancement, and any adverse developments in the company's products or services may materially and adversely affect its business, financial condition, results of operations, and cash flows.
  • Changing regulations in India could lead to new compliance requirements that are uncertain. The regulatory environment in which the company operates is evolving and is subject to change.
  • The company relies on third-party transporters for sourcing raw materials from its suppliers and delivering products to the company's customers. The absence of formal agreements with these providers exposes it to risks of delays, disruptions, and non-performance, which may adversely impact the company's business, financial condition, and results of operations.
  • Delays in execution of the company's orders may lead to cost escalation and adversely affect its financial performance.
  • The company will not receive any proceeds from the Offer for Sale portion.
  • The company has in the past entered into related party transactions and may continue to do so in the future, may potentially involve conflicts of interest and impose certain liabilities on the Company.
  • The company's success depends largely upon the services of its Directors, Promoter and other Key Managerial Personnel and the company's ability to attract and retain them.
  • The company's Promoter and WTD does not has any prior experience of being a director in any other listed company in India.
  • The company's Promoters and members of the Promoter Group will continue jointly to retain majority control over the Company after the Offer, which will allow them to determine the outcome of matters submitted to shareholders for approval.
  • The company's inability to procure and/or maintain adequate insurance cover in connection with its business may adversely affect the company's results of operations, cash flows and financial condition.
  • If the company is unable to update and enhance its existing products and services in a timely manner to keep pace with technological advancements and industry developments in the forensic sector, the company's customer satisfaction, competitiveness and operating results may be adversely affected.
  • Absence of comparable publicly listed companies may adversely affect investor perception, valuation, and marketability of the company's Securities.
  • The company's inability to manage inventory in an effective manner could affect its business.
  • Changing regulations in India could lead to new compliance requirements that are uncertain. The regulatory environment in which the company operates is evolving and is subject to change.
  • The Weighted average cost of acquisition of Equity Shares by the company's Promoters is lower than the issue price.
  • An inability to manage the company's growth could disrupt its business and reduce the company's profitability.
  • The company has issued Equity Shares during the preceding twelve months at a price which may be below the Issue Price.
  • The company's success depends largely upon the knowledge and experience of its Promoters and other Key Managerial Personnel. Any loss of the company's key managerial personnel or its ability to attract and retain them may adversely affect the company's business, operations and financial condition.
  • As the company continues to expand, managing its growth and the increasing complexity of the company's business may become challenging, potentially harming its brand and financial performance.
  • The company has relied on third-party industry sources i.e., D&B Report, and any inaccuracies in or reliance on such information may adversely affect investor perception.
  • The company's ability to pay dividends in the future may be affected by any material adverse effect on its future earnings, financial condition cash flows, working capital requirements, capital expenditures and restrictive covenants in the company's financing arrangements.
  • The Price of the company's Equity Shares may be volatile, or an active trading market may not develop.
  • The company cannot assure you that its equity shares will be listed on the SME platform of BSE in a timely manner or at all, which may restrict your ability to dispose of the equity shares.
  • Sale of Equity Shares by the company's Promoters or other significant shareholder(s) may adversely affect the trading price of the Equity Shares.
  • After this Issue, the price of the Equity Shares may be highly volatile, or an active trading market for the Equity Shares may not develop.
  • The Issue price of the company's Equity Shares may not be indicative of the market price of its Equity Shares after the Issue and the market price of the company's Equity Shares may decline below the issue price and you may not be able to sell your Equity Shares at or above the Issue Price.

The Issue type of Kwick Forensic Solutions Ltd is Book Building - SME.

The minimum application for shares of Kwick Forensic Solutions Ltd is 3200.

The total shares issue of Kwick Forensic Solutions Ltd is 5641600.

Public offer of 56,41,600 equity shares of face value of Rs. 10 each ("Equity Shares") of Kwick Forensic Solutions Limited (the "Company" or the "Issuer") for cash at a price of Rs. 90 per equity share (the "Offer Price") aggregating to Rs. 50.77 Crores ("the Offer") comprising of a fresh issue of 45,61,600 equity shares aggregating to Rs. 41.05 Crores (the "Fresh Issue") and an offer for sale of up to 10,80,000 equity shares by Shammer Saralal Shah, Sejal Shammer Shah and Tulsidas Hinduja Ashok Kumar ("the Promoter Selling Shareholders") aggregating to Rs. 9.72 Crores ("Offer for Sale") of which 2,83,200 shares aggregating to Rs. 2.55 Crores will be reserved for subscription by market maker to the offer (the "Market Maker Reservation Portion"). The public offer less the market maker reservation portion i.e. Net offer of 53,58,400 equity shares aggregating to Rs. 48.23 Crores (the "Net Offer"). The public offer and the net offer will constitute 26.32% and 25.00% respectively of the post issue paid up equity share capital of the company. Price Band: Rs. 90/- per equity share of face value Rs. 10/- each. The floor price is 9.00 times of the face value of the equity shares. Bids can be made for a minimum of 3,200 equity shares and in multiples of 1,600 equity shares thereafter.